We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+0.82%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$187B
AUM Growth
-$1.41B
Cap. Flow
-$2.94B
Cap. Flow %
-1.58%
Top 10 Hldgs %
24.38%
Holding
10,185
New
1,269
Increased
3,519
Reduced
3,507
Closed
1,718

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$940M
2
GLD icon
SPDR Gold Trust
GLD
+$375M
3
C icon
Citigroup
C
+$202M
4
GILD icon
Gilead Sciences
GILD
+$150M
5
M icon
Macy's
M
+$81.3M

Sector Composition

Rank Sector Weight
1 Technology 1.75%
2 Financials 1.43%
3 Consumer Discretionary 0.87%
4 Healthcare 0.87%
5 Energy 0.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRNX
8401
DELISTED
Taronis Technologies, Inc. Common Stock
TRNX
$11K ﹤0.01%
+1
New +$13.6K
WRN
8402
Western Copper and Gold
WRN
$581M
$10K ﹤0.01%
+12,422
New +$7.78K
CVO
8403
DELISTED
Cenevo, Inc.
CVO
$10K ﹤0.01%
+1,567
New +$9.13K
TGB
8404
Trekor Metals
TGB
$3.38B
$9K ﹤0.01%
+17,675
New +$9.34K
UQM
8405
DELISTED
UQM Technologies, Inc.
UQM
$9K ﹤0.01%
+15,002
New +$10.7K
GLRI
8406
DELISTED
GLORI ENERGY INC COMMON STOCK
GLRI
$9K ﹤0.01%
38,934
-20,862
-35% -$4.58K
NWBO
8407
CALL
DELISTED
Northwest Biotherapeutics, Inc. Common stock
NWBO
$9K ﹤0.01%
14,700
-82,000
-85% -$87.5K
MBOT icon
8408
Microbot Medical
MBOT
$102M
$8K ﹤0.01%
+153
New +$44.1K
NAVB
8409
PUT
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$8K ﹤0.01%
720
+15
+2% +$295
DSKX
8410
DELISTED
DS HEALTHCARE GROUP, INC. NEW COMMON STOCK
DSKX
$8K ﹤0.01%
62,340
+10,330
+20% +$7.83K
ARP
8411
CALL
DELISTED
ATLAS RESOURCE PARTNERS L P COM UIT REPSTG LTD PTNRS
ARP
$8K ﹤0.01%
15,200
-7,300
-32% -$3.76K
JXG
8412
JX Luxventure
JXG
$105M
$7K ﹤0.01%
+2
New +$5.79K
IPDN icon
8413
Professional Diversity Network
IPDN
$1.63M
$6K ﹤0.01%
101
-126
-56% -$10.2K
MSN icon
8414
Emerson Radio
MSN
$9.47M
$6K ﹤0.01%
+10,973
New +$8.1K
NVCN
8415
DELISTED
Neovasc Inc.
NVCN
0
YUMA
8416
DELISTED
Yuma Energy Inc
YUMA
$6K ﹤0.01%
+63
New +$4.96K
TPLM
8417
DELISTED
Triangle Petroleum Corporation
TPLM
$6K ﹤0.01%
+19,741
New +$7.48K
PTX
8418
PUT
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
$6K ﹤0.01%
1,390
-180
-11% -$1.18K
CPHI icon
8419
China Pharma Holdings
CPHI
$38.7M
$5K ﹤0.01%
+40
New +$4.49K
BDR
8420
DELISTED
Blonder Tongue Laboratories Inc
BDR
$5K ﹤0.01%
10,469
-21,197
-67% -$8.63K
OREX
8421
CALL
DELISTED
Orexigen Therapeutics, Inc.
OREX
$5K ﹤0.01%
1,250
-210
-14% -$949
KMI.WS
8422
DELISTED
Kinder Morgan Inc
KMI.WS
$5K ﹤0.01%
297,819
+3,601
+1% +$100
CDMO
8423
CALL
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$4K ﹤0.01%
1,614
-10,086
-86% -$28.1K
FCRE
8424
DELISTED
FC Global Realty Incorporated Common Stock
FCRE
$4K ﹤0.01%
+3,325
New +$5.38K
DXI
8425
DELISTED
DXI ENERGY INC COM SHS (CDA)
DXI
$4K ﹤0.01%
+29,317
New +$4.81K

Similar funds

Jeff Yass's Q2 2016 Portfolio in Review

As of Q2 2016, Jeff Yass held 10,185 positions worth $187B, down 0.75% from $188B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Jeff Yass's Q2 2016 filing shows 1,269 new, 3,519 increased, 3,507 reduced and 1,718 closed positions. Its largest new stake was Vanguard Long-Term Bond ETF: 484,542 shares worth $47.5M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $7.28B.

By sector, the portfolio is most concentrated in Technology at 1.8% of assets, up from 1.6% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Jeff Yass's largest Q2 2016 buy was Vanguard Long-Term Bond ETF: 484,542 shares worth $47.5M.
  • Jeff Yass added most to Apple in Q2 2016, an estimated $940M increase.
  • Jeff Yass's biggest Q2 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $7.28B.
  • Jeff Yass fully exited iShares MSCI Emerging Markets ETF in Q2 2016, selling an estimated $700M.
  • Jeff Yass's ten largest holdings make up 24% of its $187B portfolio in Q2 2016.
  • Jeff Yass opened 1,269 new positions and closed 1,718 in Q2 2016.
  • Jeff Yass's portfolio value fell 0.75% quarter-over-quarter to $187B.

Based on Susquehanna International Group's 13F filing for Q2 2016, filed 15 Aug 2016.